You are here

  • Home
  • Archive
  • Volume 9, Issue Suppl 2
  • PO.5.101 The effect of belimumab on renal outcomes in a pre-specified subgroup analysis of a phase 3 randomised trial in a european population with lupus nephritis

Citation Tools

Article menu

Download PDFPDF

Friday 07 October 2022 from 13:00 to 14:10
PO.5 E- poster session 5: lupus nephritis
PO.5.101 The effect of belimumab on renal outcomes in a pre-specified subgroup analysis of a phase 3 randomised trial in a european population with lupus nephritis

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Andreoli L, Amoura Z, Morales E, et al
PO.5.101 The effect of belimumab on renal outcomes in a pre-specified subgroup analysis of a phase 3 randomised trial in a european population with lupus nephritis
Lupus Science & Medicine 2022;9:doi: 10.1136/lupus-2022-elm2022.125